{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:51Z","timestamp":1783181151115,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","award":["APP1145657"],"award-info":[{"award-number":["APP1145657"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2002576"],"award-info":[{"award-number":["APP2002576"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Institute","award":["1R21EB030349-01"],"award-info":[{"award-number":["1R21EB030349-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11033-021-06398-7","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T18:02:20Z","timestamp":1621620140000},"page":"3979-3989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Overexpression of miRNA-9 enhances galectin-3 levels in oral cavity cancers"],"prefix":"10.1007","volume":"48","author":[{"given":"Yunxia","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Dun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Blick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-8259","authenticated-orcid":false,"given":"Chamindie","family":"Punyadeera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"6","key":"6398_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"6398_CR2","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.2147\/CMAR.S171251","volume":"10","author":"SW Chen","year":"2018","unstructured":"Chen SW, Zhang Q, Guo ZM, Chen WK, Liu WW, Chen YF et al (2018) Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution. Cancer Manag Res 10:4523\u20134535","journal-title":"Cancer Manag Res"},{"issue":"12","key":"6398_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4103\/1947-2714.123239","volume":"5","author":"KB Jadhav","year":"2013","unstructured":"Jadhav KB, Gupta N (2013) Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise. N Am J Med Sci 5(12):671\u2013679","journal-title":"N Am J Med Sci"},{"issue":"36","key":"6398_CR4","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","volume":"31","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31(36):4550\u20134559. https:\/\/doi.org\/10.1200\/JCO.2013.50.3870","journal-title":"J Clin Oncol"},{"issue":"12","key":"6398_CR5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.oraloncology.2013.09.001","volume":"49","author":"HS van Monsjou","year":"2013","unstructured":"van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ (2013) Head and neck squamous cell carcinoma in young patients. Oral Oncol 49(12):1097\u20131102","journal-title":"Oral Oncol"},{"issue":"1","key":"6398_CR6","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41598-019-38797-z","volume":"9","author":"K Bozinovic","year":"2019","unstructured":"Bozinovic K, Sabol I, Dediol E, Milutin Gasperov N, Manojlovic S, Vojtechova Z et al (2019) Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer. Sci Rep 9(1):2306","journal-title":"Sci Rep"},{"issue":"8","key":"6398_CR7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/14737159.2014.960519","volume":"14","author":"C Salazar","year":"2014","unstructured":"Salazar C, Calvopina D, Punyadeera C (2014) miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Expert Rev Mol Diagn 14(8):1033\u20131040","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"6398_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.oraloncology.2011.11.006","volume":"48","author":"J Minor","year":"2012","unstructured":"Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ et al (2012) Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol 48(1):73\u201378","journal-title":"Oral Oncol"},{"issue":"29","key":"6398_CR9","doi-asserted-by":"crossref","first-page":"20838","DOI":"10.18632\/oncotarget.24889","volume":"9","author":"K Nowek","year":"2018","unstructured":"Nowek K, Wiemer EAC, Jongen-Lavrencic M (2018) The versatile nature of miR-9\/9(*) in human cancer. Oncotarget 9(29):20838\u201320854","journal-title":"Oncotarget"},{"issue":"59","key":"6398_CR10","doi-asserted-by":"crossref","first-page":"99990","DOI":"10.18632\/oncotarget.21725","volume":"8","author":"Y Wan","year":"2017","unstructured":"Wan Y, Vagenas D, Salazar C, Kenny L, Perry C, Calvopina D et al (2017) Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients. Oncotarget 8(59):99990\u2013100001","journal-title":"Oncotarget"},{"key":"6398_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/0145561319893861","author":"S Tokmak","year":"2019","unstructured":"Tokmak S, Ar\u0131k D, P\u0131narba\u015fl\u0131 \u00d6, G\u00fcrb\u00fcz MK, A\u00e7\u0131kal\u0131n MF (2019) Evaluation and prognostic significance of galectin-3 expression in oral squamous cell carcinoma. Ear Nose Throat J. https:\/\/doi.org\/10.1177\/0145561319893861","journal-title":"Ear Nose Throat J"},{"issue":"24","key":"6398_CR12","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1158\/0008-5472.CAN-07-3233","volume":"67","author":"P Nangia-Makker","year":"2007","unstructured":"Nangia-Makker P, Raz T, Tait L, Hogan V, Fridman R, Raz A (2007) Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res 67(24):11760\u201311768","journal-title":"Cancer Res"},{"issue":"2","key":"6398_CR13","first-page":"305","volume":"9","author":"A Krzeslak","year":"2004","unstructured":"Krzeslak A, Lipinska A (2004) Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 9(2):305\u2013328","journal-title":"Cell Mol Biol Lett"},{"key":"6398_CR14","doi-asserted-by":"crossref","first-page":"e29103","DOI":"10.4161\/tisb.29103","volume":"2","author":"M Viguier","year":"2014","unstructured":"Viguier M, Advedissian T, Delacour D, Poirier F, Deshayes F (2014) Galectins in epithelial functions. Tissue Barriers 2:e29103","journal-title":"Tissue Barriers"},{"key":"6398_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2016.00127","volume":"6","author":"AC Cardoso","year":"2016","unstructured":"Cardoso AC, Andrade LN, Bustos SO, Chammas R (2016) Galectin-3 determines tumor cell adaptive strategies in stressed tumor microenvironments. Front Oncol 6:127","journal-title":"Front Oncol"},{"issue":"2","key":"6398_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbagen.2009.07.005","volume":"1800","author":"KC Haudek","year":"2010","unstructured":"Haudek KC, Spronk KJ, Voss PG, Patterson RJ, Wang JL, Arnoys EJ (2010) Dynamics of galectin-3 in the nucleus and cytoplasm. Biochim Biophys Acta 1800(2):181\u2013189","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"6398_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12253-013-9603-7","volume":"19","author":"LP Wang","year":"2013","unstructured":"Wang LP, Chen SW, Zhuang SM, Li H, Song M (2013) Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt\/beta-catenin-dependent pathway. Pathol Oncol Res 19(3):461\u2013474","journal-title":"Pathol Oncol Res"},{"key":"6398_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-020-01195-3","author":"JD Coppock","year":"2020","unstructured":"Coppock JD, Mills AM, Stelow EB (2020) Galectin-3 expression in high-risk hpv-positive and negative head & neck squamous cell carcinomas and regional lymph node metastases. Head Neck Pathol. https:\/\/doi.org\/10.1007\/s12105-020-01195-3","journal-title":"Head Neck Pathol"},{"issue":"9","key":"6398_CR19","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/MLG.0b013e31817b0718","volume":"118","author":"S Saussez","year":"2008","unstructured":"Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D et al (2008) Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 118(9):1583\u20131590","journal-title":"Laryngoscope"},{"issue":"12","key":"6398_CR20","first-page":"4635","volume":"6","author":"Y Honjo","year":"2000","unstructured":"Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J et al (2000) Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6(12):4635\u20134640","journal-title":"Clin Cancer Res"},{"issue":"42","key":"6398_CR21","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/onc.2013.448","volume":"33","author":"T Yu","year":"2014","unstructured":"Yu T, Liu K, Wu Y, Fan J, Chen J, Li C et al (2014) MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt\/beta-catenin signaling pathway. Oncogene 33(42):5017\u20135027","journal-title":"Oncogene"},{"issue":"8","key":"6398_CR22","first-page":"1754","volume":"46","author":"A Shang","year":"2018","unstructured":"Shang A, Lu WY, Yang M, Zhou C, Zhang H, Cai ZX et al (2018) miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4\/6 pathway. Artif Cells Nanomed Biotechnol 46(8):1754\u20131762","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"12","key":"6398_CR23","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/1878-0261.12352","volume":"12","author":"HM Hersi","year":"2018","unstructured":"Hersi HM, Raulf N, Gaken J, Folarin N, Tavassoli M (2018) MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4. Mol Oncol 12(12):2023\u20132041","journal-title":"Mol Oncol"},{"key":"6398_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/jcar.JCar_17_18","volume":"17","author":"S Lakshminarayana","year":"2018","unstructured":"Lakshminarayana S, Augustine D, Rao RS, Patil S, Awan KH, Venkatesiah SS et al (2018) Molecular pathways of oral cancer that predict prognosis and survival: a systematic review. J Carcinog 17:7","journal-title":"J Carcinog"},{"issue":"3","key":"6398_CR25","first-page":"287","volume":"10","author":"RB Krishna Prasad","year":"2013","unstructured":"Krishna Prasad RB, Sharma A, Babu HM (2013) An insight into salivary markers in oral cancer. Dent Res J (Isfahan) 10(3):287\u2013295","journal-title":"Dent Res J (Isfahan)"},{"issue":"19","key":"6398_CR26","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.3390\/ijms20194799","volume":"20","author":"Z Nowicka","year":"2019","unstructured":"Nowicka Z, Stawiski K, Tomasik B, Fendler W (2019) Extracellular miRNAs as biomarkers of head and neck cancer progression and metastasis. Int J Mol Sci 20(19):4799","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6398_CR27","first-page":"1947","volume":"18","author":"T Nosratzehi","year":"2017","unstructured":"Nosratzehi T, Alijani E, Moodi M (2017) Salivary MMP-1, MMP-2, MMP-3 and MMP-13 levels in patients with oral lichen planus and squamous cell carcinoma. Asian Pac J Cancer Prev 18(7):1947\u20131951","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"6398_CR28","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1158\/1055-9965.EPI-11-0503","volume":"20","author":"M Stott-Miller","year":"2011","unstructured":"Stott-Miller M, Houck JR, Lohavanichbutr P, Mendez E, Upton MP, Futran ND et al (2011) Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 20(12):2628\u20132636","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"6398_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/cancers11040473","volume":"11","author":"KD Tang","year":"2019","unstructured":"Tang KD, Baeten K, Kenny L, Frazer IH, Scheper G, Punyadeera C (2019) Unlocking the potential of saliva-based test to detect HPV-16-driven oropharyngeal cancer. Cancers 11(4):473","journal-title":"Cancers"},{"issue":"8","key":"6398_CR30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung EZ, Gershenwald JE (2018) The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther 18(8):775\u201384","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"6398_CR31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/rcm.6806","volume":"28","author":"Y Xu","year":"2014","unstructured":"Xu Y, Bailey UM, Punyadeera C, Schulz BL (2014) Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and liquid chromatography\/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 28(5):471\u2013482","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"2","key":"6398_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/biom10020223","volume":"10","author":"KD Tang","year":"2020","unstructured":"Tang KD, Menezes L, Baeten K, Walsh LJ, Whitfield BCS, Batstone MD et al (2020) Oral HPV16 prevalence in oral potentially malignant disorders and oral cavity cancers. Biomolecules 10(2):223","journal-title":"Biomolecules"},{"key":"6398_CR33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fonc.2020.00408","volume":"10","author":"KD Tang","year":"2020","unstructured":"Tang KD, Vasani S, Taheri T, Walsh LJ, Hughes BGM, Kenny L et al (2020) An occult HPV-driven oropharyngeal squamous cell carcinoma discovered through a saliva test. Front Oncol 10:408","journal-title":"Front Oncol"},{"issue":"10","key":"6398_CR34","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1111\/cas.14585","volume":"111","author":"KD Tang","year":"2020","unstructured":"Tang KD, Vasani S, Menezes L, Taheri T, Walsh LJ, Hughes BGM et al (2020) Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma. Cancer Sci 111(10):3854\u20133861","journal-title":"Cancer Sci"},{"issue":"5","key":"6398_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13402-014-0188-2","volume":"37","author":"C Salazar","year":"2014","unstructured":"Salazar C, Nagadia R, Pandit P, Cooper-White J, Banerjee N, Dimitrova N et al (2014) A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol (Dordr) 37(5):331\u2013338","journal-title":"Cell Oncol (Dordr)"},{"key":"6398_CR36","first-page":"163","volume":"57","author":"M Toth","year":"2001","unstructured":"Toth M, Fridman R (2001) Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography. Methods Mol Med 57:163\u2013174","journal-title":"Methods Mol Med"},{"issue":"18","key":"6398_CR37","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4155\/bio.13.190","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, Wan Y, Cooper-White J, Dimeski G, Atherton J, Punyadeera C (2013) Quantification of D-dimer levels in human saliva. Bioanalysis 5(18):2249\u20132256","journal-title":"Bioanalysis"},{"issue":"1","key":"6398_CR38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12885-018-4656-3","volume":"18","author":"L van der Merwe","year":"2018","unstructured":"van der Merwe L, Wan Y, Cheong HJ, Perry C, Punyadeera C (2018) A pilot study to profile salivary angiogenic factors to detect head and neck cancers. BMC Cancer 18(1):734","journal-title":"BMC Cancer"},{"key":"6398_CR39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.12659\/MSM.895683","volume":"22","author":"L Sun","year":"2016","unstructured":"Sun L, Liu L, Fu H, Wang Q, Shi Y (2016) Association of decreased expression of serum mir-9 with poor prognosis of oral squamous cell carcinoma patients. Med Sci Monit 22:289\u2013294","journal-title":"Med Sci Monit"},{"issue":"43","key":"6398_CR40","doi-asserted-by":"crossref","first-page":"26125","DOI":"10.1074\/jbc.M115.651489","volume":"290","author":"Y Mori","year":"2015","unstructured":"Mori Y, Akita K, Yashiro M, Sawada T, Hirakawa K, Murata T et al (2015) Binding of galectin-3, a \u03b2-galactoside-binding lectin, to MUC1 protein enhances phosphorylation of extracellular signal-regulated kinase 1\/2 (ERK1\/2) and AKT, promoting tumor cell malignancy. J Biol Chem 290(43):26125\u201326140","journal-title":"J Biol Chem"},{"issue":"3","key":"6398_CR41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D et al (2010) miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12(3):247\u2013256","journal-title":"Nat Cell Biol"},{"issue":"1","key":"6398_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/aps.2012.150","volume":"34","author":"D Zhang","year":"2013","unstructured":"Zhang D, Chen ZG, Liu SH, Dong ZQ, Dalin M, Bao SS et al (2013) Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating beta-catenin. Acta Pharmacol Sin 34(1):176\u2013184","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"6398_CR43","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.bbamcr.2013.04.017","volume":"1833","author":"A Santiago-Gomez","year":"2013","unstructured":"Santiago-Gomez A, Barrasa JI, Olmo N, Lecona E, Burghardt H, Palacin M et al (2013) 4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation of galectin-3 and beta-catenin signaling, and MMP-2 expression. Biochim Biophys Acta 1833(9):2045\u20132056","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"6398_CR44","first-page":"1035e1","volume":"138","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Choi IJ, Cheong TC, Lee SJ, Lotan R, Park SH et al (2010) Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138(3):1035e1-1045e2","journal-title":"Gastroenterology"},{"issue":"22","key":"6398_CR45","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1158\/0008-5472.CAN-12-2424","volume":"72","author":"RR Braeuer","year":"2012","unstructured":"Braeuer RR, Zigler M, Kamiya T, Dobroff AS, Huang L, Choi W et al (2012) Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. Cancer Res 72(22):5757\u20135766","journal-title":"Cancer Res"},{"issue":"5","key":"6398_CR46","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3892\/ijo.2016.3430","volume":"48","author":"YR Park","year":"2016","unstructured":"Park YR, Lee ST, Kim SL, Liu YC, Lee MR, Shin JH et al (2016) MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Int J Oncol 48(5):2135\u20132143","journal-title":"Int J Oncol"},{"issue":"9","key":"6398_CR47","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-05-0104","volume":"65","author":"T Shimura","year":"2005","unstructured":"Shimura T, Takenaka Y, Fukumori T, Tsutsumi S, Okada K, Hogan V et al (2005) Implication of galectin-3 in Wnt signaling. Cancer Res 65(9):3535\u20133537","journal-title":"Cancer Res"},{"issue":"11","key":"6398_CR48","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1101\/gad.14.11.1319","volume":"14","author":"FT Kolligs","year":"2000","unstructured":"Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR et al (2000) gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 14(11):1319\u20131331","journal-title":"Genes Dev"},{"issue":"5","key":"6398_CR49","doi-asserted-by":"crossref","first-page":"e64088","DOI":"10.1371\/journal.pone.0064088","volume":"8","author":"YJ Chen","year":"2013","unstructured":"Chen YJ, Lee LY, Chao YK, Chang JT, Lu YC, Li HF et al (2013) DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF\/LEF-Myc\/cyclin D1\/MMP signaling pathway. PLoS ONE 8(5):e64088","journal-title":"PLoS ONE"},{"issue":"1","key":"6398_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jop.12952","volume":"49","author":"J Fang","year":"2020","unstructured":"Fang J, Xiao L, Zhang Q, Peng Y, Wang Z, Liu Y (2020) Junction plakoglobin, a potential prognostic marker of oral squamous cell carcinoma, promotes proliferation, migration and invasion. J Oral Pathol Med 49(1):30\u201338","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"6398_CR51","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.cdd.4400443","volume":"5","author":"C Brancolini","year":"1998","unstructured":"Brancolini C, Sgorbissa A, Schneider C (1998) Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin\/plakoglobin during apoptosis. Cell Death Differ 5(12):1042\u20131050","journal-title":"Cell Death Differ"},{"issue":"19","key":"6398_CR52","doi-asserted-by":"crossref","first-page":"32270","DOI":"10.18632\/oncotarget.15650","volume":"8","author":"Z AKTary","year":"2017","unstructured":"AKTary Z, Alaee M, Pasdar M (2017) Beyond cell-cell adhesion: plakoglobin and the regulation of tumorigenesis and metastasis. Oncotarget 8(19):32270\u201332291","journal-title":"Oncotarget"},{"issue":"14","key":"6398_CR53","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1158\/1078-0432.CCR-16-2814","volume":"23","author":"F Citron","year":"2017","unstructured":"Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D\u2019Andrea S et al (2017) An integrated approach identifies mediators of local recurrence in head and neck squamous carcinoma. Clin Cancer Res 23(14):3769\u20133780","journal-title":"Clin Cancer Res"},{"issue":"6","key":"6398_CR54","first-page":"4133","volume":"19","author":"E Nweke","year":"2020","unstructured":"Nweke E, Ntwasa M, Brand M, Devar J, Smith M, Candy G (2020) Increased expression of plakoglobin is associated with upregulated MAPK and PI3K\/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma. Oncol Lett 19(6):4133\u20134141","journal-title":"Oncol Lett"},{"issue":"4","key":"6398_CR55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1593\/neo.122098","volume":"15","author":"ED Wickline","year":"2013","unstructured":"Wickline ED, Du Y, Stolz DB, Kahn M, Monga SP (2013) gamma-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after beta-catenin knockdown. Neoplasia 15(4):421\u2013434","journal-title":"Neoplasia"},{"issue":"3","key":"6398_CR56","doi-asserted-by":"crossref","first-page":"101042831769592","DOI":"10.1177\/1010428317695920","volume":"39","author":"VG Manasa","year":"2017","unstructured":"Manasa VG, Kannan S (2017) Impact of microRNA dynamics on cancer hallmarks: an oral cancer scenario. Tumour Biol 39(3):1010428317695920","journal-title":"Tumour Biol"},{"issue":"7385","key":"6398_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482(7385):347\u2013355","journal-title":"Nature"},{"issue":"4","key":"6398_CR58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijom.2005.07.023","volume":"35","author":"G Ueda","year":"2006","unstructured":"Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y et al (2006) Aberrant expression of \u03b2- and \u03b3-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35(4):356\u2013361","journal-title":"Int J Oral Maxillofac Surg"},{"key":"6398_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2014.12.038","volume":"442","author":"S Aggarwal","year":"2015","unstructured":"Aggarwal S, Sharma SC, Das SN (2015) Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population. Clin Chim Acta 442:13\u201321","journal-title":"Clin Chim Acta"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06398-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06398-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06398-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T07:00:02Z","timestamp":1672210802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06398-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["6398"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06398-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Queensland (UQ) Medical Ethical Institutional Board (HREC No: 2014000679 and 2014000862), the Princess Alexandra Hospital (PAH) Ethics Review Board (HREC\/12\/QPAH\/381) and Queensland University of Technology (QUT) (HREC No: 1400000617 and 1400000641).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the participants provided written informed consent prior to recruitment and sample collection and could withdraw at any time. The study was performed in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}